![Jeremy Cress](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeremy Cress
Chief Tech/Sci/R&D Officer at Castle Creek Biosciences, Inc.
Jeremy Cress active positions
Companies | Position | Start | End |
---|---|---|---|
Castle Creek Biosciences, Inc.
![]() Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Corporate Officer/Principal | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Chief Operating Officer | - | - |
Career history of Jeremy Cress
Statistics
International
United States | 2 |
Operational
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Castle Creek Biosciences, Inc.
![]() Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Health Technology |
- Stock Market
- Insiders
- Jeremy Cress
- Experience